Watch Globalive Media Featuring RNA Diagnostics, Jeremy Bridge

Measuring the effectiveness of cancer treatments is a challenge among the healthcare community. New technology is now able to provide physicians with the resources to either improve or change the treatment plan in order to be most effective for the patient. Jeremy Bridge-Cook President and CEO, Rna Diagnostics talks to Anthony Lacavera about how these advancements are changing the way primary cancer treatments are managed.